Paramedic Papers

Home Toxicology Prehospital flumazenil: 69 doses, no seizures

Toxicology

Prehospital flumazenil: 69 doses, no seizures

Prehospital Flumazenil: Five-Year Review of Use, Indications, Outcomes, and Adverse Events in Suspected Benzodiazepine Overdose
The Western Journal of Emergency Medicine · 2026-07-31 · Added 22 October 2026

A five-year Kansas review of 69 prehospital flumazenil administrations for suspected benzodiazepine overdose found clinical improvement with no seizures or adverse events recorded, even where possible contraindications existed.

Study type
Cohort
Design
Retrospective observational cohort
Participants
69 prehospital flumazenil administrations over five years
Main finding
No seizures or adverse events were associated with flumazenil use (0/69; 95% CI 0–4.3%), with GCS improvement in the treated cases
Caveat
A tiny retrospective sample with a confidence interval wide enough to hide a real 4% adverse-event rate
Bottom line
Context only

Why it matters in Australia (Medium relevance). No Australian ambulance service carries flumazenil, so adoption would need a guideline change — the value here is challenging the reflex that the antidote is too risky for the road.

Learning goal

Weigh the risks and benefits of benzodiazepine reversal in overdose, given flumazenil is not carried by Australian services.

Open in dashboard Read the paper (DOI) PubMed

More

Related papers on Toxicology